Search
Search Results
##search.searchResults.foundPlural##
-
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3136PDF: 750HTML: 2918Figure 1a and 1b: 136Figure 2: 142Figure 3: 164Figure 4: 143Figure 5: 148Tables 1-5: 141 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2004PDF: 1612HTML: 347 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1565PDF: 1141HTML: 184 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7292PDF: 2378HTML: 1708Table 1.: 190Table 2.: 204Table 3.: 185Table 4.: 182 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4258PDF: 1455HTML: 1534Untitled: 211 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3677PDF: 1530HTML: 8008Randi Fig: 163 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2808PDF: 1395HTML: 3038Cover Letter: 186 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
694PDF: 499Suppl. Files: 115HTML: 79 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1235PDF: 591HTML: 3061 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1034PDF: 747HTML: 274 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3661PDF: 1056HTML: 2263Figure 1: 197 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2189PDF: 835HTML: 2066 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1917PDF: 688HTML: 670Table1: patient's characteristics: 141Table 2: profile of each patient: 165 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1704PDF: 505HTML: 16959Figure 4: 150Figure 3: 126Figure 2: 129Figure 1: 157 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
709PDF: 454HTML: 6248 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1894PDF: 776HTML: 206 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
793PDF: 527HTML: 4005 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3452PDF: 1583HTML: 2662 -
A A RETROSPECTIVE LONG-TERM STUDY ON AGE AT MENARCHE AND MENSTRUAL CHARACTERISTICS IN 85 YOUNG WOMEN WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (TDT) BORN BETWEEN 1965 AND 1995 Long-Term Study on Age at Menarche and Menstrual Characteristics in patients with TDT
1445PDF: 463HTML: 164 -
Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM):Implications for Clinical Practice OGTT concordance rate in thalassemia major
544PDF: 397Html: 95 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3109PDF: 1103HTML: 1460Untitled: 161Untitled: 148Untitled: 154 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1003PDF: 936HTML: 305 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
414PDF: 222HTML: 71 -
-







